Video-Assisted Thoracoscopic Day Surgery for Patients with Pulmonary Nodules: A Single-Center Clinical Experience of 200 Cases.

BACKGROUND: We reviewed our experience with 200 patients who underwent video-assisted thoracoscopic day surgery (VATDS) at the Day Surgery Center at West China Hospital to identify the safety and feasibility of VATDS and assess the value of novel management in patients with pulmonary nodules.
METHODS: Between June 2019 and December 2020, 200 patients with pulmonary nodules underwent VATDS at the Day Surgery Center at West China Hospital. The medical records of these 200 patients were reviewed for age, sex, preoperative history, operative and pathological findings, amount of daily chest tube drainage, procedure method and duration, length of stay (LOS), visual analog scale (VAS), and postoperative pulmonary complications (PPCs).
RESULTS: There were 45 male and 155 female patients with a median age of 43 years (range 18 to 58 years). A total of 158 (79.00%) patients were diagnosed with lung adenocarcinoma, 35 (17.50%) were diagnosed with chronic inflammation with fibrous hyperplasia, and seven (3.50%) were diagnosed with granulomatous inflammation with necrosis. The mean LOS of the 200 patients was 1.25±0.95 days, and 187 (93.50%) patients were discharged within 24 hours as planned. Thirteen patients were transferred to the thoracic surgery ward for further treatment because of PPCs. The median VAS was 3 points (range 1 to 7 points), and the rate of PPCs was 11.50%.
CONCLUSION: Two hundred patients underwent VATDS with an acceptable 24-hour discharge rate. However, selection of patients for VATDS is required, and the implementation of VATDS on a larger scale requires further discussion.

Introduction

The advent and widespread acceptance of enhanced recovery after surgery (ERAS) have attracted great interest for a wide range of surgical specialties in the management of patients, aiming to minimize perioperative stress responses and catabolism and morbidity rates, shorten the length of stay (LOS), and enhance postoperative recovery to achieve an early return to normal life.1–3 The ERAS program has been fully implemented in our medical group, and the clinical effects have been shown in previous studies.4,5 Currently, different ERAS management practices are used in different specialties, and further studies are still in progress.6–11 How to make full use of the advantages of ERAS is worth further discussion and research. Therefore, we conducted video-assisted thoracic day surgery (VATDS) for a group of selected patients with pulmonary nodules.

Day surgery is currently a safe and cost-effective medical model that is popular in developed countries, such as America and European countries.12,13 Additionally, day surgery in China has developed gradually.14 The Chinese Ambulatory Surgery Alliance defines day surgery as a planned surgery that is performed, and the patient is discharged within 24 hours, excluding outpatient surgery. The definition of day surgery in West China Hospital is a planned surgery that is performed, and the patient is discharged within 24 hours, excluding outpatient surgery, but the patient can stay overnight, which is similar to extended recovery of day surgery in the United Kingdom.15 Currently, the Day Surgery Center was built in West China Hospital, which has covered many kinds of day surgeries. If patients with pulmonary nodules can undergo VATDS in a day surgery center and be discharged on the first day after surgery, which is within 24 hours after admission, the medical resources may be fully utilized, and the hospital costs will be reduced because of the lower LOS. However, only a few studies have reported the day surgery mode of thoracic surgery.16–18

Day surgery is a pathway of clinical management, not a specific kind of surgery or procedure, which may contribute to the better outcome of the ERAS model. Thus, the implementation of ERAS in thoracic surgery may lead to the success of VATDS for a group of patients with pulmonary nodules. Therefore, the clinical experience of patients undergoing VATDS at the Day Surgery Center at West China Hospital was reviewed to identify the safety and feasibility of VATDS and assess the value of novel management in patients with pulmonary nodules.

Patients and Methods

Ethical Review

This study was registered in the Chinese Clinical Trial Registry before submission (Chi-CTR 2000034999). This study was approved by Ethics Committee on Biomedical Research, West China Hospital of Sichuan University (Number: 2020-341) and the Chinese Ethics Committee of Registering Clinical Trials and adhered to the tenets of the Declaration of Helsinki. Additionally, written informed consent was obtained from the patients. The work has been reported in line with the STROCSS criteria.19

Inclusion and Exclusion Criteria

Patients were included if they met the following inclusion criteria: 1) were between 18 and 60 years old; 2) undergoing VATS anatomical pulmonary resection; 3) no severe comorbidities, such as chronic obstructive pulmonary disease (COPD) or hypertension; 4) an American Standards Association (ASA) score of ≤2 points; and 5) a pulmonary nodule diameter that was less than 3 cm.

Patients were excluded if they met the following exclusion criteria: 1) informed consent was not signed or 2) radiotherapy, chemotherapy or pulmonary operation were received before the surgery.

Patient Selection and Education

Data from patients with pulmonary nodules who underwent thoracoscopic anatomical pulmonary resection in the same medical group at the Day Surgery Center of our hospital from June 2019 to December 2020 were continuously collected. Two weeks before surgery, patients were examined by head, chest and upper abdomen-enhanced CT, pulmonary function tests, blood tests, blood biochemical tests, and electrocardiogram as preoperative evaluations.20 On the day before surgery, patients and their families were informed in detail of surgical expectations and the risk of complications. Informed consent was signed in the surgeon’s office.

Surgical Approach

VATS was mainly performed via the three-portal thoracoscopic technique and double-lumen endotracheal intubation, combined with intravenous anesthesia and single lung ventilation.21 The thoracoscopy entrance was selected to be 1.5 cm in the 7th intercostal space anterior to the midaxillary line; the main operation port was in the 3rd or 4th intercostal space; and the auxiliary operation port was located at the 9th intercostal space behind the axillary line. When performing systemic lymph node dissection, the left nodes were dissected in groups 5, 6, 7, 8, 9 and 10, and the right nodes were dissected in groups 2, 4, 7, 8, 9 and 10.

ERAS Program Management

Perioperative Fluid Management

Fluid management encompassed the pre-, intra- and post-operative periods.22,23 Carbohydrate loading and the avoidance of starvation ensured that patients were not dehydrated prior to the induction of anesthesia preoperatively.24 Balanced crystalloids were used for liquid input during and after the operation, and the volume was controlled at approximately 1–2 mL/kg/hour. The positive liquid balance was maintained at <1500 mL (or 20 mL/kg/24 hours) during the perioperative period.25

Chest Drainage Management

Single chest tube drainage was performed after surgery.4 An 18F silicone Foley catheter was inserted through a port wound in the third or 4th intercostal middle axillary line and then descended toward the dorsal region (Figure 1). When the patient regained consciousness 4 hours after returning to the ward, chest tube removal was performed if the lung remained fully expanded from the chest X-ray and no air leak was observed in the water seal chamber. The chest tube could be removed safely even if the daily serous effusion was of a high volume (up to 450 mL/24 h).26

Figure 1

(A–C) The 18F silicone Foley catheter was inserted into the thoracic cavity and filled with 15 mL sterile water to be fixed on the Parietal pleura, no need for suture to fix.

No Catheterization Management

Patients were instructed to empty their bladders before surgery, and no urinary catheters were inserted during the operation.27 When patients had difficulty urinating after the surgery, they were promptly informed of several methods, including taking a semi-recumbent or sitting position with warm compression, rinsing the vulva, and listening to the sound of running water. Patients urinated intermittently using a urinary tube if necessary.

Regional Anesthesia and Pain Relief

Patients were asked about their drug allergy history in detail. Parecoxib sodium (40 mg, Pharmacia & Upjohn Company LLC, batch number: H20171071) was injected 1 hour before surgery for preemptive anesthesia.28 At the end of the surgery, thoracoscopic intercostal nerve blocks (TINBs) were administered by infiltration of a local anesthetic mixture (15 mL for each intercostal space) from the third to the 9th intercostal nerves under the parietal pleura, 2 cm lateral to the sympathetic chain (Figure 2).29 When returning to the ward, 40 mg parecoxib sodium was injected 8 hours after surgery.30 If necessary, nonsteroidal anti-inflammatory drugs (NSAIDs), oral sustained-release ibuprofen capsules or ammonia phenolic oxycodone tablets were provided to the patient.

Figure 2

(A–C) TINB were administered by infiltration of local anesthetic mixture (15 mL for each intercostal space) from the third to the ninth intercostal nerve under the parietal pleura, 2 cm lateral to the sympathetic chain, using an infusion needle.

MCT Treatment

Patients were treated with a short-term medium-chain triglyceride (MCT) diet after surgery.31,32 Four hours after the operation, when the patient was conscious, 100 mL of warm water was taken. If there was no nausea or vomiting after 6 to 8 hours, the patient drank 250 mL of appetizing liquid, which was used to accelerate the recovery of gastrointestinal function. The patient took 50 g of nutritional powder and 250 mL of warm water 10 to 12 hours after surgery. On the first day after surgery, the nutrition department provided dietary guidance.

Discharge Criterion

The discharge standards for the patient were set in five categories: 1) vital signs, which included blood pressure and pulse; 2) activity and mental status; 3) nausea and vomiting; 4) surgical bleeding; and 5) pain. The possibility of discharge was evaluated using the post anesthesia discharge scoring system (PADSS) score until patients had a score of 9 or higher, allowing their discharge.33 Details are provided in .

Post Discharge Management

To better ensure patient condition after discharge, the nurse communicated with patients and their family by telephone every day during the first week and on the 14th and 28th days after discharge. If there was an emergency requiring medical intervention, the follow-up nurse notified the thoracic surgeon as soon as possible to deal with it in a timely manner. When patients experienced complications, such as bleeding or breaking pain, during the follow-up after day surgery, the patient or his family members were guided to perform simple treatments or transferred to the community hospital contracted by our hospital for treatment. If necessary, an ambulance from the emergency department was arranged to take the patient to the hospital, and the surgeons were informed to stay in the emergency department to treat the patient. Then, the patient was admitted to the thoracic surgery ward for further treatment.

Results

Characteristics of the Patients

There were 45 male and 155 female patients, with a median age of 43 years old (range 18 to 58 years). Four patients had a history of hypertension, four patients had a history of surgery, which included two appendectomies, one cholecystectomy and one benign breast nodule resection, and two patients had diabetes. No one had a history of current smoking.

The basic information on the patients with VATDS is shown in Table 1. In 87 (43.50%) cases, the tumor was in the left lung, while 113 (56.50%) cases were in the right lung. Lobectomy was performed in 73 patients, segmentectomy was performed in 118 patients, and wedge excision was performed in nine patients. The mean length of operation was 72.47±21.59 minutes, and the average blood loss was 42.43±1.43 mL. Out of 200 patients, 158 (79.00%) patients were diagnosed with lung adenocarcinoma, 35 (17.50%) were diagnosed with benign nodules, including chronic inflammation with fibrous hyperplasia, and seven (3.50%) were diagnosed with granulomatous inflammation with necrosis. The mean LOS of the 200 patients was 1.25±0.95 days, and 187 (93.50%) patients were discharged within 24 hours as planned. A total of 13 patients were transferred to the thoracic surgery ward for further treatment because of postoperative complications (PPCs). The median visual analog scale (VAS) was 3 points (range 1 to 7 points).

Table 1

Preoperative, Operative, and Postoperative Characteristics of Patients Included in the Study

Total of Patients	200
Gender, n (%)
Male	45 (22.50%)
Female	155 (77.50%)
Age (years)
Median (range)	43 (18~58)
Comorbidities, n (%)
Hypertension	4 (2.00%)
Surgical history	4 (2.00%)
Type 2 diabetes	2 (1.00%)
Surgical location, n (%)
Right	87 (43.50%)
Left	113 (56.50%)
Surgical approaches, n (%)
Lobectomy	73 (36.50%)
Segmentectomy	118 (59.00%)
Wedge excision	9 (4.50%)
Operative time (minutes)
Mean ± SD	72.47±21.59
Intraoperative blood loss(mL)
Mean ± SD	42.43±1.43
Pathology, n (%)
Adenocarcinoma	158 (79.00%)
Benign	42 (21.00%)
Postoperative complications, n (%)
PAL	9 (4.50%)
Pneumothorax	4 (2.00%)
Bleeding	4 (2.00%)
Pleural effusion	2 (1.00%)
Hoarseness	2 (1.00%)
Chylothorax	1 (0.50%)
Pulmonary infection	1 (0.50%)
Outcome, n (%)
Planned discharge	187(93.50%)
Transfer to in-hospital	13 (6.50%)
Mean LOS (day)
Mean ± SD	1.25±0.95
VAS
Median (range)	3 (1~7)

Abbreviations: SD, standard deviation; PAL, persistent air leakage; LOS, length of stay; VAS, visual analogue score.

Surgical Approaches

Patients who underwent VATDS were all admitted because of pulmonary nodules. Since different types of surgery may influence the prognosis of patients, a comparison between different surgical approaches was conducted. Lobectomy was performed in 73 patients, segmentectomy was performed in 118 patients and wedge excision in nine. Considering the PPCs, no significant difference was found among the three groups of patients, as shown in Table 2. In addition, although the operative approaches were different, there was no statistically significant difference in the operative time, mean length of stay, blood loss or hospital cost, as shown in Table 3.

Table 2

Comparison of PPCs Among Different Surgical Approaches

	LG (n=73)	SG (n=118)	WEG (n=9)	P value
PAL	4	4	1	0.360
Pneumothorax	2	2	0	0.819
Pleural effusion	1	1	0	0.906
Hoarseness	1	1	0	0.906
Bleeding	1	2	1	0.793
Chylothorax	1	0	0	0.423
Pulmonary infection	0	1	0	0.711
Total	10	12	1	0.742

Abbreviations: PPCs, postoperative complications; PAL, persistent air leakage; LG, lobectomy group; SG, segmentectomy group; WEG, wedge excision group.

Table 3

Treatment-Related Costs and Resource Consumption Among Different Surgical Approaches

	LG(n=73)	SG(n=118)	WEG(n=9)	P value
Length of operation (min)
Mean ± SD	74.99±18.76	70.87±22.61	74.14±30.66	0.915
Blood loss(mL)
Mean ± SD	32.14±8.92	38.62±10.34	33.13±3.74	0.759
LOS (day)
Mean ± SD	1.27±1.06	1.24±0.89	1.29±0.76	0.231
Hospital cost (USD)
Mean ± SD	5639.17±832.22	5264.96±842.50	5414.41±899.59	0.782

Abbreviations: SD, standard deviation; LOS, length of stay; USD, united states dollar; LG, lobectomy group; SG, segmentectomy group; WEG, wedge excision group.

Pathological Diagnosis

In these 200 patients who underwent VATDS, a total of 158 (79.00%) patients were diagnosed with lung adenocarcinoma, and benign pathological diagnosis was diagnosed in 42 (21.00%) patients, which included chronic inflammation with fibrous hyperplasia and granulomatous inflammation with necrosis. The primary TNM stage of the 158 patients was stage I, and only one patient was stage II because of mediastinal lymph node metastasis. Among the 42 patients with a benign diagnosis, chronic inflammation with fibrous hyperplasia was observed in 35 (17.50%) patients, and granulomatous inflammation with necrosis was observed in 7 (3.50%) patients. When comparing the PPCs between the two groups, although persistent air leakage, pneumothorax, bleeding and pulmonary infection occurred more easily in the malignant group, no significant difference was found. Hoarseness and chylothorax are specially related complications that result from lymph node dissection, which may explain the difference. Details are shown in Table 4.

Table 4

Comparison of PPCs Between Different Pathological Diagnoses

	Benign (n=42)	Malignant (n=158)	P value
PAL	3	6	0.353
Pneumothorax	0	4	0.298
Pleural effusion	1	1	0.312
Hoarseness	0	2	0.464
Bleeding	1	3	0.843
Chylothorax	0	1	0.605
Pulmonary infection	0	1	0.605
Total	5	18	0.833

Abbreviations: PPCs, postoperative complications; PAL, persistent air leakage.

Failure Cases

Of the 200 VATDS patients, a total of 187 (93.50%) patients were discharged within 24 hours as planned, but 13 patients were transferred to the thoracic surgery ward for further treatment because of PPCs. Among the 13 patients who were not discharged within 24 hours, nine patients had air leakage, and four patients had postoperative bleeding. In these nine air leakage patients, six patients underwent right-side surgery, and the fissure was undeveloped in three of them, two patients had extensive pleural adhesion, and one patient had right upper lobe posterior segment (S2) resection and right lower lobe dorsal segment (S6) resection, which may have contributed to persistent air leakage (PAL). For these four bleeding patients, one patient’s pulmonary artery was broken during the operating process and repaired with hemostatic clamps after thoracotomy. The patient was transferred to the thoracic surgery ward for further observation. The other three patients’ chest drainage volume per hour was more than 200 mL and persisted for three hours after surgery. Among the three postoperative bleeding patients, one patient underwent thoracoscopic hemostasis surgery because of surgical incision bleeding and was transferred to the thoracic ward, and the other two patients were transferred after using hemostatic methods, such as carbazochrome sodium sulfonate. Four patients’ vital signs recovered, and they were discharged after several days of observation. The information on the 13 patients is listed in Table 5.

Table 5

Information of Failure Cases

	Age	Sex	BMI	Reason	Operation Approach	Surgical Site	Histology	Intraoperative Situation	Treatment	LOS
Patient 1	41	Female	23.18	PAL	Lobectomy	RUL	Adenocarcinoma	Undeveloped fissure	Chest drainage	4
Patient 2	39	Female	17.82	PAL	Lobectomy	RLL	Adenocarcinoma	Undeveloped fissure	Chest drainage	4
Patient 3	31	Female	21.51	PAL	Segmentectomy	LUL S1+2	Adenocarcinoma	Extensive pleural adhesion	Chest drainage	4
Patient 4	56	Female	24.46	PAL	Segmentectomy	RLL S6	Adenocarcinoma		Chest drainage	6
Patient 5	42	Female	24.75	PAL	Segmentectomy	RUL S1+2	Adenocarcinoma		Chest drainage	5
Patient 6	47	Male	23.45	PAL	Segmentectomy	LUL S1+2	Adenocarcinoma		Chest drainage	4
Patient 7	32	Female	22.68	PAL	Segmentectomy	RUL S2 & RLL S6	Adenocarcinoma		Chest drainage	6
Patient 8	28	Female	21.63	PAL	Wedge excision	LUL	Granuloma	Extensive pleural adhesion	Chest drainage	5
Patient 9	33	Male	24.34	PAL	Lobectomy	RUL	Fibrous hyperplasia	Undeveloped fissure	Chest drainage	2
Patient 10	35	Female	25.85	Bleeding	Segmentectomy	LUL S3	Adenocarcinoma	Pulmonary artery broken	Thoracotomy	5
Patient 11	44	Male	18.52	Bleeding	Segmentectomy	RLL S6	Adenocarcinoma		Re-operation	5
Patient 12	51	Female	26.84	Bleeding	Lobectomy	LUL	Adenocarcinoma		Hemostatic	3
Patient 13	50	Male	27.53	Bleeding	Segmentectomy	RLL S7	Adenocarcinoma		Hemostatic	4

Abbreviations: BMI, body mass index; PAL, persistent air leakage; RUL, right upper lobe; RLL, right lower lobe; LUL, left upper lobe; S1+2, apico-posterior segment; S2, posterior segment; S3, anterior segment; S6, dorsal segment; S7, anterior basal segment.

Discussion

The VATDS study flow is shown in Figure 3, which briefly explains the VATDS mode. To our knowledge, this is the first report of VATDS in a day surgery center with such large number of patients.

Figure 3

Study flow of VATDS.

Most of the 200 patients with VATDS were female, young, without serious comorbidities or a history of smoking, and they were likely to have a shorter postoperative recovery period than older patients. In addition, surgeries were mainly segmentectomy with lymph node sampling or dissection, which is related to the popularity of current lung cancer screening methods. More lung tumors can be detected early and removed surgically in a timely manner. However, it also means that the implementation of VATDS is limited because of the high selection of patients with pulmonary nodules. Most patients in our study were non-smoker young women, which is clearly not representative of the daily work of other centers for lung cancer. Older men with a history of smoking have always been the main group of lung cancer patients. Thus, careful selection of patients for VATDS is highly required, and the implementation of VATDS on a larger scale needs further discussion.

When the surgical approaches and pathological diagnoses were reviewed, we found that segmentectomy and adenocarcinoma accounted for a large part. Since one of the inclusion criteria of VATDS was that the diameter of the pulmonary nodules was less than 3 cm, in which patients with advanced lung cancer may have been ruled out, most patients had a diagnosis of micro-invasive adenocarcinoma (MIA) or adenocarcinoma in situ (AIS) after surgery. To minimize the damage to lung tissue during surgery on the premise of sufficient surgical margin, segmentectomy is preferred, thus ensuring that VATDS is relatively easier to perform and patients in a day surgery center may recover faster than advanced lung cancer patients to meet the discharge criteria of a day surgery center. According to our study, LOS, PPCs and hospital cost were not different between the lobectomy group and segmentectomy group, and although the operative approaches were different, there was no statistically significant difference in operative time. After the surgery records review, we found that one patient in the wedge excision group underwent pleural adhesion cautery because of extensive adhesion in the thoracic cavity, which led to a longer surgery duration (115 minutes) and postoperative complications (persistent air leakage). Another patient in the wedge section group underwent a 120-minute surgery because of pulmonary artery bleeding, which took much time for hemostasis. Two patients were transferred to the thoracic surgery ward and discharged after a few days when their condition was stable. Due to the small sample size of wedge resection patients, the data from these two patients may have a significant impact on the operative time and medical costs, which may explain the outcome. In addition, a more comprehensive selection of patients and more careful steps in surgery need to be done for the sake of patients.

Among the 200 day surgery patients in this study, although the discharge rate within 24 hours (93.50%) was acceptable, the factors that made the 6.50% patients in this study unable to be discharged require further clarification Among the nine patients who were not discharged within 24 hours, nine patients had air leakage, and four patients had postoperative bleeding. Persistent air leakage (PAL) is one of the major complications after lung surgery. According to previous studies,34,35 the incidence of PAL is approximately 10%, which is more common in male patients and patients with preoperative pulmonary dysfunction (such as emphysema and COPD), lobotomy, pleural adhesion, low body mass index (BMI), right-side surgery, and underdeveloped fissures.36–41 Of the nine patients with air leakage, six underwent surgery on the right side, of which three had underdeveloped fissures. Two patients had pleural adhesion that could lead to PAL. The ERAS team in Italy42 recommended that prevention of air leakage is an important component of ERAS and that high-risk patients should take certain measures, such as pleural tent, surgical sealant, and staple-line reinforcement. In the day surgery center in particular, the discharge of day surgery patients was limited by air leakage. Therefore, a method to prevent air leakage should be developed when necessary. In addition, Bao and his team reported the safety of thoracic tube discharge in selected patients43 after pulmonary surgery. Further studies are needed to validate this approach, and it would be meaningful in the management of VATDS.

Due to China’s population and medical resources, it is important to make full and rational use of medical resources. This novel approach for early-stage NSCLC patients with fewer conditions may lessen medical pressure in China. However, VATDS is still in exploration; thus, it may not be made in all selected patients even though they meet the inclusion criteria. Among the 200 patients that underwent day surgery, a total of 23 patients had postoperative complications: nine patients had PAL, four patients developed pneumothorax, four patients developed hemorrhage after surgery, two patients had hoarseness after surgery, two patients had pleural effusion, one had chylothorax, and one had pulmonary infection. The rate of PPCs in VATDS patients (11.5%) was acceptable compared with standard VATS inpatients.44 Thus, it is feasible to encourage this management for selected patients with pulmonary nodules.

Perhaps a “short” length of stay is not an accurate indicator to evaluate the quality of surgery. However, the safety and feasibility may be confirmed by the clinical outcomes of these 200 VATDS patients. For patients without serious complications, VATDS may achieve the effect of in-hospital surgery without increasing the perioperative risk.

Limitations

There are some limitations that we cannot ignore. First, this was a retrospective study rather than a randomized controlled trial and may inevitably have been confounded by other factors. A control group of traditional VATS will be made in our further study to compare the safety, feasibility and medical economics between day surgery and in-hospital surgery. Second, the study selected patients receiving VATS for pulmonary nodules, which may have limited us to generalization of relevant conclusions. Furthermore, we only discussed the patients in the day surgery center after strict selection. As shown in the discussion section, most patients were nonsmoker young women, which may be inapplicable to all other lung cancer centers, and careful selection of patients for VATDS is highly required; thus, the spread of VATDS is limited. Finally, patients should have a longer follow-up period with a comprehensive assessment, including a quality-of-life assessment, which needs to be considered in future research. A multicenter, prospective study is needed to further confirm the safety and feasibility of VATDS.

Conclusion

Two hundred patients underwent VATDS with an acceptable 24-hour discharge rate. Thirteen delayed-discharge patients recovered well and were discharged after treatment for several days. Thus, careful selection of patients for VATDS is required, and the implementation of VATDS on a larger scale needs further study.